Out of stock

This item is currently unavailable

Out of stock for 21 days. Get on the list — one email the moment it's back.

Out of stock 21 days

World Outlook 2025-2030: Psychiatric and Substance Abuse Hospitals

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 21 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

The 2025-2030 World Outlook for Psychiatric and Substance Abuse Hospitals provides essential industry analysis and projections. Produced by ICON Group International, Inc., this publication serves as a specialized resource for professionals monitoring the landscape of mental health and addiction treatment facilities. It offers a dedicated look at the evolving trends and market dynamics expected through the year 2030. This book is categorized for academic and professional research within the subjects field, making it a targeted tool for understanding the future of psychiatric and substance abuse hospital sectors.

Key Features

Covers the 2025-2030 outlook for psychiatric and substance abuse hospital sectors.

Published by ICON Group International, Inc. for professional industry use.

Provides a specialized focus on mental health and addiction treatment hospital trends.

Categorized as a subject-specific book for research and industry analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
09 April 2024

Similar Products You Might Like

US Antipsychotic Drug Outlook for Schizophrenia 2023-2028
97% match

US Antipsychotic Drug Outlook for Schizophrenia 2023-2028

£520.00 28 Oct 2026
Schizophrenia Drugs US Outlook 2023-2028 Market Study
96% match

Schizophrenia Drugs US Outlook 2023-2028 Market Study

£520.00 08 Nov 2026
The 2023-2028 Outlook for Substance Abuse Treatments in the United States
96% match

The 2023-2028 Outlook for Substance Abuse Treatments in the United States

£520.00 11 Oct 2026
The 2023-2028 Outlook for Substance Abuse Treatments in India
96% match

The 2023-2028 Outlook for Substance Abuse Treatments in India

£515.00 10 Oct 2026
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
96% match

The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants

£795.00 28 Oct 2026
Schizophrenia Treatment Outlook 2023-2028 - US Market Study
96% match

Schizophrenia Treatment Outlook 2023-2028 - US Market Study

£520.00 08 Nov 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan
96% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan

£495.00 04 Nov 2026
The 2023-2028 Outlook for Schizophrenia Drugs in Japan
96% match

The 2023-2028 Outlook for Schizophrenia Drugs in Japan

£495.00 04 Nov 2026
The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan
96% match

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan

£495.00 26 Sep 2026
The 2023-2028 Outlook for Substance Abuse Treatments in Japan
96% match

The 2023-2028 Outlook for Substance Abuse Treatments in Japan

£495.00 17 Oct 2026
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
96% match

The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs

£885.00 02 Nov 2026
The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan
96% match

The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan

£495.00 04 Nov 2026
The 2023-2028 Outlook for Schizophrenia Treatments in Japan
96% match

The 2023-2028 Outlook for Schizophrenia Treatments in Japan

£495.00 30 Oct 2026
World Outlook for Stress Management Treatments 2025-2030
96% match

World Outlook for Stress Management Treatments 2025-2030

Price unavailable
The 2027-2032 World Outlook for Alcoholism Rehabilitation Hospitals
96% match

The 2027-2032 World Outlook for Alcoholism Rehabilitation Hospitals

£890.00 14 Oct 2026
Anxiety and Depression Outlook 2023-2028 - ICON Group
96% match

Anxiety and Depression Outlook 2023-2028 - ICON Group

£520.00 06 Nov 2026
US Anxiety and Depression Treatment Outlook 2023-2028 Study
96% match

US Anxiety and Depression Treatment Outlook 2023-2028 Study

£520.00 08 Nov 2026
World Outlook for Mobile Medical Monitoring Apps 2025-2030
96% match

World Outlook for Mobile Medical Monitoring Apps 2025-2030

Price unavailable
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
96% match

The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics

Price unavailable
World Outlook for Advanced Therapy Medicinal Products 2025-2030
96% match

World Outlook for Advanced Therapy Medicinal Products 2025-2030

Price unavailable
World Outlook for Healthcare Professional Medical Apps
96% match

World Outlook for Healthcare Professional Medical Apps

Price unavailable
2023-2028 Antipsychotic Drug Outlook - US Zip Code Study
96% match

2023-2028 Antipsychotic Drug Outlook - US Zip Code Study

£490.00 21 Oct 2026
2025-2030 World Outlook for Life Science Products Study
96% match

2025-2030 World Outlook for Life Science Products Study

Price unavailable
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
96% match

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

£885.00 04 Nov 2026